Joincare Pharmaceutical Group Industry Co Ltd Total Assets
Joincare Pharmaceutical Group Industry Co Ltd total assets. Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) holds total assets worth CN¥34.72 Billion CNY (≈ $5.08 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 600380 market cap for the company's overall valuation and market capitalisation.
Total Assets of Joincare Pharmaceutical Group Industry Co Ltd (1997–2025)
Total assets of Joincare Pharmaceutical Group Industry Co Ltd from 1997 to 2025. This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's total assets have evolved over time, based on quarterly financial data. See current stock price of Joincare Pharmaceutical Group Industry C for real-time trading data and today's change.
Joincare Pharmaceutical Group Industry Co Ltd - Asset Composition Analysis
Joincare Pharmaceutical Group Industry Co Ltd Total Assets Breakdown (December 2025)
Joincare Pharmaceutical Group Industry Co Ltd total assets breakdown as of December 2025. Joincare Pharmaceutical Group Industry Co Ltd's total assets of CN¥34.72 Billion consist of 65.4% current assets and 34.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 38.4% |
| Accounts Receivable | CN¥2.72 Billion | 7.7% |
| Inventory | CN¥2.21 Billion | 6.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥1.25 Billion | 3.5% |
| Goodwill | CN¥636.34 Million | 1.8% |
Asset Composition Trend (1997–2025)
This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Joincare Pharmaceutical Group Industry C's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Joincare Pharmaceutical Group Industry Co Ltd's current assets represent 65.4% of total assets in 2025, an increase from 52.3% in 1997.
- Cash Position: Cash and equivalents constituted 38.4% of total assets in 2025, up from 30.0% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 1997.
- Asset Diversification: The largest asset category is accounts receivable at 7.7% of total assets.
Joincare Pharmaceutical Group Industry Co Ltd Competitors by Total Assets
Key competitors of Joincare Pharmaceutical Group Industry Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥9.94 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321
|
China | CN¥3.63 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829
|
China | CN¥7.35 Billion |
Joincare Pharmaceutical Group Industry Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.03 | 2.57 | 2.25 |
| Quick Ratio | 1.78 | 2.32 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥9.80 Billion | CN¥14.29 Billion | CN¥10.09 Billion |
Joincare Pharmaceutical Group Industry Co Ltd - Advanced Valuation Insights
This section examines the relationship between Joincare Pharmaceutical Group Industry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.11 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -0.9% |
| Total Assets | CN¥35.41 Billion |
| Market Capitalization | $2.82 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Joincare Pharmaceutical Group Industry Co Ltd's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Joincare Pharmaceutical Group Industry Co Ltd's assets decreased by 0.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Joincare Pharmaceutical Group Industry Co Ltd (1997–2025)
The table below shows the annual total assets of Joincare Pharmaceutical Group Industry Co Ltd from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥35.41 Billion ≈ $5.18 Billion |
-0.85% |
| 2024-12-31 | CN¥35.72 Billion ≈ $5.23 Billion |
-1.76% |
| 2023-12-31 | CN¥36.36 Billion ≈ $5.32 Billion |
+1.76% |
| 2022-12-31 | CN¥35.73 Billion ≈ $5.23 Billion |
+14.87% |
| 2021-12-31 | CN¥31.10 Billion ≈ $4.55 Billion |
+10.47% |
| 2020-12-31 | CN¥28.16 Billion ≈ $4.12 Billion |
+10.69% |
| 2019-12-31 | CN¥25.44 Billion ≈ $3.72 Billion |
+1.81% |
| 2018-12-31 | CN¥24.99 Billion ≈ $3.66 Billion |
+12.49% |
| 2017-12-31 | CN¥22.21 Billion ≈ $3.25 Billion |
+38.20% |
| 2016-12-31 | CN¥16.07 Billion ≈ $2.35 Billion |
+16.50% |
| 2015-12-31 | CN¥13.80 Billion ≈ $2.02 Billion |
+14.16% |
| 2014-12-31 | CN¥12.08 Billion ≈ $1.77 Billion |
+12.46% |
| 2013-12-31 | CN¥10.75 Billion ≈ $1.57 Billion |
+10.16% |
| 2012-12-31 | CN¥9.75 Billion ≈ $1.43 Billion |
+10.66% |
| 2011-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
+24.01% |
| 2010-12-31 | CN¥7.11 Billion ≈ $1.04 Billion |
+15.65% |
| 2009-12-31 | CN¥6.15 Billion ≈ $899.35 Million |
+5.58% |
| 2008-12-31 | CN¥5.82 Billion ≈ $851.85 Million |
-3.21% |
| 2007-12-31 | CN¥6.01 Billion ≈ $880.09 Million |
+26.73% |
| 2006-12-31 | CN¥4.75 Billion ≈ $694.45 Million |
+8.05% |
| 2005-12-31 | CN¥4.39 Billion ≈ $642.68 Million |
-0.49% |
| 2004-12-31 | CN¥4.41 Billion ≈ $645.86 Million |
-0.05% |
| 2003-12-31 | CN¥4.42 Billion ≈ $646.17 Million |
+75.01% |
| 2002-12-31 | CN¥2.52 Billion ≈ $369.22 Million |
+8.42% |
| 2001-12-31 | CN¥2.33 Billion ≈ $340.56 Million |
+206.42% |
| 2000-12-31 | CN¥759.52 Million ≈ $111.14 Million |
+11.36% |
| 1999-12-31 | CN¥682.04 Million ≈ $99.80 Million |
+14.98% |
| 1998-12-31 | CN¥593.19 Million ≈ $86.80 Million |
+32.20% |
| 1997-12-31 | CN¥448.72 Million ≈ $65.66 Million |
-- |
About Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and tradi… Read more